BIOMAT Database Logo BIOMAT Database Logo

Genetic investigation of patients with hypercholesterolemia type IIa. 1999

C Szalai, and A Császár, and A Czinner, and T Palicz, and B Halmos, and L Romics

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006580 Genetic Carrier Screening Identification of individuals who are heterozygous at a GENETIC LOCUS for a recessive PHENOTYPE. Carriers, Genetic, Detection,Genetic Carriers, Detection,Heterozygote Detection,Carrier Detection, Genetic,Detection, Genetic Carrier,Genetic Carrier Detection,Heterozygote Screening,Carrier Screening, Genetic,Detection, Heterozygote,Screening, Genetic Carrier,Screening, Heterozygote,Screenings, Genetic Carrier
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Szalai, and A Császár, and A Czinner, and T Palicz, and B Halmos, and L Romics
Platelets and coagulation in patients with familial hypercholesterolemia (type IIa).
January 1983, Acta medica Scandinavica,
C Szalai, and A Császár, and A Czinner, and T Palicz, and B Halmos, and L Romics
Genetic analysis of Indian subjects with clinical features of possible type IIa hypercholesterolemia.
January 2007, Journal of clinical laboratory analysis,
C Szalai, and A Császár, and A Czinner, and T Palicz, and B Halmos, and L Romics
Pseudo-homozygous type IIa hypercholesterolemia.
August 1997, Indian pediatrics,
C Szalai, and A Császár, and A Czinner, and T Palicz, and B Halmos, and L Romics
[The rheumatism in type IIa hypercholesterolemia].
April 1986, Revue du rhumatisme et des maladies osteo-articulaires,
C Szalai, and A Császár, and A Czinner, and T Palicz, and B Halmos, and L Romics
Formation of isoprostanes in children with type IIa hypercholesterolemia.
August 2001, Journal of cardiovascular pharmacology,
C Szalai, and A Császár, and A Czinner, and T Palicz, and B Halmos, and L Romics
Increased thromboxane biosynthesis in type IIa hypercholesterolemia.
May 1992, Circulation,
C Szalai, and A Császár, and A Czinner, and T Palicz, and B Halmos, and L Romics
Soluble P-selectin and proinflammatory cytokines in patients with polygenic type IIa hypercholesterolemia.
January 1999, Haemostasis,
C Szalai, and A Császár, and A Czinner, and T Palicz, and B Halmos, and L Romics
Migratory polyarthritis in familial hypercholesterolemia (type IIa hyperlipoproteinemia).
March 2010, Indian journal of pediatrics,
C Szalai, and A Császár, and A Czinner, and T Palicz, and B Halmos, and L Romics
[Historical xanthomata revealing a familial hypercholesterolemia type IIa].
January 2015, The Pan African medical journal,
C Szalai, and A Császár, and A Czinner, and T Palicz, and B Halmos, and L Romics
The conservative treatment of xanthoma of the Achilles tendon in patients affected with type IIA hypercholesterolemia.
January 1996, La Chirurgia degli organi di movimento,
Copied contents to your clipboard!